Pfizer Inc.
A maker of medicines and vaccines, Pfizer produces well-known drugs like the blood thinner Eliquis, the Prevnar pneumonia vaccines, the Covid shot Comirnaty, the antiviral Paxlovid, and cancer treatments Ibrance and Xtandi, used by patients around the world. It was founded in 1849 in Brooklyn by German cousins Charles Pfizer, a chemist, and Charles Erhart, a confectioner, who began by coating a bitter worm medicine in almond-flavored toffee candy. Its most famous discovery, the erectile-dysfunction drug Viagra, was a happy accident—originally developed as a heart medication for angina.
Granted 1.82M · Sold 2.06M
Granted 854.6K · Sold 245.0K
Granted 7.64M · Sold 2.40M
Granted 737.0K
Granted 342.7K · Sold 159.9K
Granted 221.9K · Sold 81.3K
Granted 4.40M · Sold 1.13M
Granted 173.0K · Sold 49.9K
Granted 159.1K · Sold 57.6K
Granted 291.3K · Sold 128.5K
Granted 1.68M · Sold 263.8K
Granted 2.59M · Sold 150.9K
Granted 120.3K
Granted 1.07M · Sold 38.5K
Granted 235.2K · Sold 70.0K
Granted 259.6K · Sold 188.5K
Granted 2.55M · Sold 798.8K
Granted 1.76M · Sold 413.9K
Granted 226.0K
Granted 405.1K · Sold 170.0K
Granted 220.3K · Sold 113.4K
Granted 128.3K
Granted 88.4K · Bought 2.0K
Granted 2.38M · Bought 5.0K · Sold 583.6K
Granted 112.0K
Granted 374.0K · Sold 200.4K
Granted 528.8K · Sold 80.6K
Granted 976.3K · Sold 498.6K
Granted 135.4K · Sold 14.8K
Granted 698.0K · Sold 314.6K
Granted 115.9K
Granted 318.9K · Sold 163.2K
Granted 148.2K · Sold 1.4K
Granted 80.0K
Granted 181.2K · Sold 26.2K
Granted 309.2K · Sold 119.5K
Granted 74.4K
Granted 164.7K
Granted 27.2K
Granted 28.8K
Granted 41.9K
Granted 177.0K
Granted 27.1K · Sold 8.2K
Granted 95.6K · Sold 32.9K
Granted 61.3K
Granted 102.1K · Sold 19.2K
Granted 22.5K
Bought 32.5K
Granted 157.2K · Sold 38.8K
Granted 43.4K
Granted 22.4K
Granted 27.9K · Sold 30.4K
Granted 23.2K · Sold 980
Granted 76.5K · Sold 28.0K
Bought 10.0K
Bought 10.0K
Granted 63.7K · Sold 30.5K
Bought 1.6K · Sold 24
Granted 887
Granted 39 · Bought 549 · Sold 14.5K
Granted 36.7K · Bought 1.9K · Sold 7.8K
Granted 3.9K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Steere William C JrDirector · 26 transactions | — | 2.59Mas of Jan 2011 | 1.82M | — | 2.06M |
| McKinnell Henry ADirector · 9 transactions | — | 2.39Mas of Mar 2007 | 854.6K | — | 245.0K |
| Read Ian CExecutive Chairman, Director · 227 transactions | — | 1.69Mas of Mar 2019 | 7.64M | — | 2.40M |
| Kindler Jeffrey BChairman & CEO, Director · 23 transactions | — | 1.66Mas of May 2010 | 737.0K | — | — |
| Katen Karen LVice Chairman · 8 transactions | — | 1.01Mas of May 2006 | 342.7K | — | 159.9K |
| Shedlarz David LVice Chairman · 12 transactions | — | 646.2Kas of Jun 2007 | 221.9K | — | 81.3K |
| Damelio Frank AExecutive Vice President · 243 transactions | — | 555.9Kas of Feb 2022 | 4.40M | — | 1.13M |
| Lamattina John LSenior Vice President · 14 transactions | — | 454.5Kas of Jul 2007 | 173.0K | — | 49.9K |
| Ricciardi Natale SSenior Vice President · 26 transactions | — | 449.4Kas of Mar 2011 | 159.1K | — | 57.6K |
| Feczko Joseph MSenior Vice President · 28 transactions | — | 422.5Kas of Mar 2009 | 291.3K | — | 128.5K |
| Young John DGroup President · 97 transactions | — | 422.1Kas of Nov 2021 | 1.68M | — | 263.8K |
| Bourla AlbertChairman & CEO, Director · 73 transactions | — | 394.7K | 2.59M | — | 150.9K |
| Mackay MartinSenior Vice President · 7 transactions | — | 386.8Kas of Mar 2010 | 120.3K | — | — |
| Lewis-Hall Freda CExecutive Vice President · 48 transactions | — | 379.6Kas of Mar 2019 | 1.07M | — | 38.5K |
| Germano Geno JGroup President · 15 transactions | — | 368.7Kas of Feb 2015 | 235.2K | — | 70.0K |
| Levin Alan GSenior Vice President · 17 transactions | — | 360.0Kas of May 2007 | 259.6K | — | 188.5K |
| Dolsten MikaelPresident R&D · 134 transactions | — | 323.7Kas of Feb 2024 | 2.55M | — | 798.8K |
| Lankler Douglas MExecutive Vice President · 160 transactions | — | 284.3K | 1.76M | — | 413.9K |
| Ringo William RSenior Vice President · 3 transactions | — | 255.1Kas of Mar 2010 | 226.0K | — | — |
| Schulman Amy WExecutive Vice President · 30 transactions | — | 253.7Kas of May 2013 | 405.1K | — | 170.0K |
| Brandicourt OlivierBusiness Unit President · 22 transactions | — | 226.0Kas of Jul 2013 | 220.3K | — | 113.4K |
| Redmond Cavan M.Group President · 5 transactions | — | 185.0Kas of Feb 2012 | 128.3K | — | — |
| Simmons David SBusiness Unit President · 10 transactions | — | 182.2Kas of Feb 2012 | 88.4K | 2.0K | — |
| Susman SallyExecutive Vice President · 236 transactions | — | 169.8Kas of Mar 2025 | 2.38M | 5.0K | 583.6K |
| Boshoff ChristoffelPresident, R&D · 21 transactions | — | 168.9K | 112.0K | — | — |
| Maddaluna Anthony JExecutive Vice President · 51 transactions | — | 165.4Kas of Feb 2017 | 374.0K | — | 200.4K |
| Johnson Rady AExecutive Vice President · 95 transactions | — | 127.2Kas of Feb 2024 | 528.8K | — | 80.6K |
| Cangialosi Loretta VSr. Vice President, Controller · 164 transactions | — | 124.8Kas of Mar 2020 | 976.3K | — | 498.6K |
| McLeod Mary SSenior Vice President · 10 transactions | — | 121.5Kas of Nov 2010 | 135.4K | — | 14.8K |
| Hill Charles HExecutive Vice President · 80 transactions | — | 110.8Kas of Mar 2018 | 698.0K | — | 314.6K |
| Pao WilliamExecutive Vice President · 2 transactions | — | 97.8Kas of Mar 2023 | 115.9K | — | — |
| Mackenzie Alexander RExecutive Vice President · 67 transactions | — | 97.6Kas of Dec 2021 | 318.9K | — | 163.2K |
| Sahni PayalExecutive Vice President · 28 transactions | — | 97.4K | 148.2K | — | 1.4K |
| Goodman Corey SSenior Vice President · 3 transactions | — | 83.3Kas of Mar 2009 | 80.0K | — | — |
| Hwang AngelaPresident, Global Biopharma · 39 transactions | — | 81.9Kas of Feb 2023 | 181.2K | — | 26.2K |
| Olson Laurie JExecutive Vice President · 61 transactions | — | 78.2Kas of Aug 2018 | 309.2K | — | 119.5K |
| de Germay AlexandreExecutive Vice President · 1 transaction | — | 74.4Kas of Feb 2024 | 74.4K | — | — |
| McDermott MichaelExecutive Vice President · 30 transactions | — | 74.3K | 164.7K | — | — |
| Waxman Allen PSenior Vice President · 7 transactions | — | 65.4Kas of Mar 2008 | 27.2K | — | — |
| Bagger Richard HSenior Vice President · 4 transactions | — | 60.4Kas of Mar 2008 | 28.8K | — | — |
| Mead Dana GDirector · 2 transactions | — | 51.3Kas of Jul 2009 | 41.9K | — | — |
| Fonseca LidiaExecutive Vice President · 10 transactions | — | 46.5K | 177.0K | — | — |
| Peck Kristin CExecutive Vice President · 10 transactions | — | 45.7Kas of Mar 2012 | 27.1K | — | 8.2K |
| Carapezzi William R JRExecutive Vice President · 15 transactions | — | 41.1Kas of May 2022 | 95.6K | — | 32.9K |
| Denton David MChief Financial Officer & EVP · 3 transactions | — | 37.9Kas of May 2024 | 61.3K | — | — |
| Goettler MichaelGroup President · 22 transactions | — | 36.8Kas of Feb 2020 | 102.1K | — | 19.2K |
| Burt Robert NDirector · 2 transactions | — | 34.7Kas of Jul 2009 | 22.5K | — | — |
| Blaylock Ronald EDirector · 9 transactions | — | 32.5Kas of Feb 2025 | — | 32.5K | — |
| Damico Jennifer B.SVP & Controller · 58 transactions | — | 31.4K | 157.2K | — | 38.8K |
| Malik AamirExecutive Vice President · 2 transactions | — | 29.5Kas of Aug 2024 | 43.4K | — | — |
| Lorch George ADirector · 1 transaction | — | 24.1Kas of Jul 2009 | 22.4K | — | — |
| Burns M AnthonyDirector · 2 transactions | — | 24.0Kas of Mar 2011 | 27.9K | — | 30.4K |
| Gray III William HDirector · 3 transactions | — | 23.3Kas of Jul 2009 | 23.2K | — | 980 |
| Rogers DawnExecutive Vice President · 19 transactions | — | 14.6Kas of May 2020 | 76.5K | — | 28.0K |
| Gottlieb ScottDirector · 6 transactions | — | 10.0Kas of Oct 2024 | — | 10.0K | — |
| Nora Johnson Suzanne MDirector · 1 transaction | — | 10.0Kas of May 2008 | — | 10.0K | — |
| Lund-Jurgensen KirstenExecutive Vice President · 19 transactions | — | 4.6Kas of Aug 2018 | 63.7K | — | 30.5K |
| Smith James CDirector · 2 transactions | — | 3.5Kas of Oct 2017 | — | 1.6K | 24 |
| Ausiello Dennis ADirector · 1 transaction | — | 2.4Kas of Oct 2009 | 887 | — | — |
| Kilts James MDirector · 11 transactions | — | 2.3Kas of Jan 2011 | 39 | 549 | 14.5K |
| Cornwell W DonDirector · 14 transactions | — | 1.0Kas of Jun 2018 | 36.7K | 1.9K | 7.8K |
| Sanger Stephen WDirector · 5 transactions | — | 85as of Jul 2015 | — | — | — |
| Mascotte John PDirector · 1 transaction | — | 0as of Oct 2009 | 3.9K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -10.68M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.